Your browser doesn't support javascript.
loading
Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial.
Clark, Louise F; Thivierge, M C; Kidd, Claire A; McGeoch, Susan C; Abraham, Prakash; Pearson, Donald W M; Horgan, Graham W; Holtrop, Grietje; Thies, Frank; Lobley, Gerald E.
Afiliación
  • Clark LF; 1The Rowett Institute of Nutrition and Health,University of Aberdeen,Aberdeen AB21 9SB,UK.
  • Thivierge MC; 1The Rowett Institute of Nutrition and Health,University of Aberdeen,Aberdeen AB21 9SB,UK.
  • Kidd CA; 1The Rowett Institute of Nutrition and Health,University of Aberdeen,Aberdeen AB21 9SB,UK.
  • McGeoch SC; 2Aberdeen Diabetes Centre,Aberdeen Royal Infirmary,Aberdeen AB25 2ZP,UK.
  • Abraham P; 2Aberdeen Diabetes Centre,Aberdeen Royal Infirmary,Aberdeen AB25 2ZP,UK.
  • Pearson DW; 2Aberdeen Diabetes Centre,Aberdeen Royal Infirmary,Aberdeen AB25 2ZP,UK.
  • Horgan GW; 3Biomathematics and Statistics Scotland,Aberdeen AB21 9SB,UK.
  • Holtrop G; 3Biomathematics and Statistics Scotland,Aberdeen AB21 9SB,UK.
  • Thies F; 1The Rowett Institute of Nutrition and Health,University of Aberdeen,Aberdeen AB21 9SB,UK.
  • Lobley GE; 1The Rowett Institute of Nutrition and Health,University of Aberdeen,Aberdeen AB21 9SB,UK.
Br J Nutr ; 115(1): 75-86, 2016 Jan 14.
Article en En | MEDLINE | ID: mdl-26537735
The effects of fish oil (FO) supplementation on glycaemic control are unclear, and positive effects may occur only when the phospholipid content of tissue membranes exceeds 14% as n-3 PUFA. Subjects (n 36, thirty-three completed) were paired based on metabolic parameters and allocated into a parallel double-blind randomised trial with one of each pair offered daily either 6 g of FO (3·9 g n-3 PUFA) or 6 g of maize oil (MO) for 9 months. Hyperinsulinaemic-euglycaemic-euaminoacidaemic (HIEGEAA) clamps (with [6,6 2H2 glucose]) were performed at the start and end of the intervention. Endogenous glucose production (EGP) and whole-body protein turnover (WBPT) were each measured after an overnight fast. The primary outcome involved the effect of oil type on insulin sensitivity related to glycaemic control. The secondary outcome involved the effect of oil type on WBPT. Subjects on FO (n 16) had increased erythrocyte n-3 PUFA concentrations >14%, whereas subjects on MO (n 17) had unaltered n-3 PUFA concentrations at 9%. Type of oil had no effect on fasting EGP, insulin sensitivity or total glucose disposal during the HIEGEAA clamp. In contrast, under insulin-stimulated conditions, total protein disposal (P=0·007) and endogenous WBPT (P=0·001) were both increased with FO. In an associated pilot study (n 4, three completed), although n-3 PUFA in erythrocyte membranes increased to >14% with the FO supplement, the enrichment in muscle membranes remained lower (8%; P<0·001). In conclusion, long-term supplementation with FO, at amounts near the safety limits set by regulatory authorities in Europe and the USA, did not alter glycaemic control but did have an impact on WBPT.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucemia / Grasas Insaturadas en la Dieta / Resistencia a la Insulina / Aceites de Pescado / Suplementos Dietéticos / Insulina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Nutr Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucemia / Grasas Insaturadas en la Dieta / Resistencia a la Insulina / Aceites de Pescado / Suplementos Dietéticos / Insulina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Nutr Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido